Sten Randahl Sörensen
Förmögenhet: 654 695 $ per 2026-06-30
Förmögenhet: 654 695 $ per 2026-06-30
Sten Randahl Sörensen is currently Chief Executive Officer & Director at Cereno Scientific AB since 2015, Chairman at SARomics Biostructures AB since 2013, and Director at SynAct Pharma AB since 2024.
Former positions include Chairman at AcuCort AB, Chairman at Stayble Therapeutics AB, Director-Secondary Prevention Products Marketing at AstraZeneca AB, and Head-International Marketing Operations at Monsanto Crop Sciences Sweden AB from 1987 to 1995.
Education includes undergraduate studies at the University of Lund.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2024-12-31 | 1 128 514 ( 0,36 % ) | 616 834 $ | 2026-06-30 | |
SYNACT PHARMA AB 0,03 % | 2024-12-31 | 17 407 ( 0,03 % ) | 37 860 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| CERENO SCIENTIFIC AB | Verkställande Direktör | 2015-09-01 |
| SYNACT PHARMA AB | Direktör/Styrelseledamot | 2024-03-20 |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Ordförande | 2013-01-01 |
| Företag | Position | Slut |
|---|---|---|
Monsanto Crop Sciences Sweden AB | Försäljning & Marknadsföring | 1995-01-01 |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Försäljning & Marknadsföring | - |
| STAYBLE THERAPEUTICS AB | Ordförande | - |
| ACUCORT AB | Ordförande | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 8 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monsanto Crop Sciences Sweden AB | |
AcuCort AB
AcuCort AB Pharmaceuticals: MajorHealth Technology Develops glucocorticoids for the patients suffering from acute allergic conditions | Health Technology |
SynAct Pharma AB
SynAct Pharma AB Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drugs for treatment inflammatory diseases | Health Technology |
SARomics Biostructures AB
SARomics Biostructures AB BiotechnologyHealth Technology Provides protein three-dimensional structure determination and structure-based drug discovery services | Health Technology |
Cereno Scientific AB
Cereno Scientific AB Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Stayble Therapeutics AB
Stayble Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a clinical stage company which develops drugs to treat disco genic chronic low back pain | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån